Bezafibrate significantly suppressed postprandial elevation of triglyceride ( incremental area under the curve ( AUC ) : 54465 vs. 1158283 mg h/dl , p = 0.02 ) and remnant lipoprotein cholesterol ( incremental AUC : 27.93.5 vs. 72.314.1 mg h/dl , p < 0.01 ) .